Integrated BioPharma (OTCMKTS:INBP – Get Free Report) issued its earnings results on Friday. The company reported ($0.04) earnings per share (EPS) for the quarter, Zacks reports. Integrated BioPharma had a negative net margin of 3.43% and a negative return on equity of 8.32%.
Integrated BioPharma Stock Performance
OTCMKTS INBP traded down $0.00 on Friday, hitting $0.18. 9,739 shares of the stock were exchanged, compared to its average volume of 10,422. The stock has a fifty day moving average price of $0.17 and a two-hundred day moving average price of $0.21. Integrated BioPharma has a 52-week low of $0.14 and a 52-week high of $0.42. The firm has a market capitalization of $5.69 million, a P/E ratio of -2.62 and a beta of 0.40.
Integrated BioPharma Company Profile
Integrated BioPharma, Inc is a health and wellness company focused on the development, manufacturing and distribution of nutritional supplements, vitamins, herbal products and related consumer health offerings. The company serves businesses and consumers seeking products in the dietary supplement and natural health categories.
Its activities have included contract manufacturing and private-label production, as well as the sale and distribution of finished nutritional and wellness products.
Further Reading
- Five stocks we like better than Integrated BioPharma
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
